Antitumor agent-180 (Compound 13a) is an inhibitor for BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B). Antitumor agent-180 inhibits the proliferation of ccRCC cell Caki-1 with IC50 of 2.047 µM. Antitumor agent-180 induces necrosis and apoptosi
Molecular Weight:
591.75
Formula:
C34H41N9O
Target:
Apoptosis
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted